Sushmita Das, M. Rani, V. Rabidas
Mar 1, 2014
Citations
0
Influential Citations
12
Citations
Journal
British Journal of Pharmacology
Abstract
The combination of paromomycin–miltefosine is a successful anti‐leishmanial therapy in visceral leishmaniasis (VL). This encouraged us to study its effect on Toll‐like receptor (TLR)‐mediated immunomodulation of dendritic cells (DC), as DC maturation and activation is crucial for anti‐leishmanial activity.